medicare glp-1 coverage obesity The weight of Why Medicare Won't Cover GLP-1

Healthcare System Implications The widespread adoption of GLP-1 medications presents both opportunities and challenges for healthcare systems: a) Cost-Benefit Calculations : Although the medications themselves are expensive (ranging from $900 to $1,300 monthly without insurance coverage), their potential to reduce obesity-related healthcare costs is substantial

Northern Kentucky resident Stefanie Fair started using a GLP-1 a year ago

However, Wegovy still delivers excellent results for many people, costs less in compounded form, and some people tolerate it better

This study of more than 16,400 subjects found a 27% increased rate of hospitalization for acute HF after approximately 2 years of saxagliptin therapy ( P = .007)

When telehealth providers hired by employers to manage costs try to get her patients to come off their obesity medications, she's alarmed

Booking a retreat where the main activity is finishing a book (does anyone else fall asleep 7 pages in?!)